Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 0.2 | 0.0 | 0.1 | 0.2 | 0.4 | 0.7 | 0.7 | 0.9 |
Revenue growth | 343.0% | -60.6% | -49.0% | -36.2% | -42.7% | -6.3% | -24.1% | -21.0% |
Cost of goods sold | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.3 | 0.2 | 0.2 |
Gross profit | 0.2 | 0.0 | 0.0 | 0.2 | 0.2 | 0.3 | 0.5 | 0.8 |
Gross margin | 91.1% | 100.0% | 21.8% | 66.0% | 54.6% | 50.8% | 75.0% | 83.6% |
Selling, general and administrative | 3.4 | 3.7 | | | | | | |
Research and development | 1.5 | 1.6 | 4.3 | 1.1 | 0.2 | 0.5 | | |
General and administrative | | | 3.2 | 4.6 | 4.4 | 2.7 | 2.5 | 2.1 |
EBIT | -5.0 | -5.4 | -7.5 | -5.6 | -4.6 | -2.9 | -2.0 | -1.5 |
EBIT margin | -2347.5% | -11121.6% | -6109.9% | -2314.7% | -1228.2% | -439.8% | -292.0% | -159.9% |
Pre-tax income | -4.4 | -5.2 | -3.5 | -6.0 | -6.6 | -29.7 | -5.9 | -4.7 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -4.4 | -5.3 | -3.5 | 6.0 | -6.6 | -29.7 | -5.9 | -4.7 |
Net margin | -2043.3% | -10934.7% | -2859.6% | 2517.4% | -1748.1% | -4519.5% | -841.3% | -504.6% |
|
Diluted EPS | ($0.61) | ($0.81) | ($0.65) | $1.72 | ($2.63) | ($12.77) | ($0.02) | ($0.03) |
Shares outstanding (diluted) | 7.2 | 6.5 | 5.4 | 3.5 | 2.5 | 2.3 | 250.2 | 155.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|